相关实验视频
Updated: Aug 10, 2026

08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
通过内皮脂酶对高密度脂蛋白代谢的剂量依赖加速
Cyrille Maugeais1, Uwe J F Tietge, Uli C Broedl
1Departments of Medicine, University of Pennsylvania, Philadelphia, Pa, USA.
Circulation
|October 1, 2003
概括
在小鼠中,内皮脂酶 (EL) 的过度表达增加了血脂酶活性和高密度脂类激素 (HDL) 代谢. 这导致HDL胆固醇和阿波脂蛋白AI水平降低,通过增加和肝脏的吸收.
科学领域:
- 脂质代谢 脂质代谢 是一种
- 心血管研究的心血管研究.
- 生物化学 生物化学
背景情况:
- 调节高密度脂蛋白 (HDL) 和阿波利波蛋白AI (apoA-I) 代谢的机制尚未完全理解.
- 在小鼠中,内皮脂酶 (EL) 的过度表达显著降低了高密度胆固醇和apoA-I水平,但根本原因尚不清楚.
研究的目的:
- 为了研究内皮脂酶 (EL) 过度表达对小鼠HDL代谢的影响.
- 阐明EL影响高密度胆固醇和apoA-I水平的机制.
主要方法:
- 在使用重组腺病毒载体在不同剂量的小鼠中过度表达人类EL.
- 评估了血脂酶活性,脂质概况,HDL颗粒大小,HDL周转动力学,以及ApoA-I的组织吸收.
主要成果:
- 随着EL过度表达的剂量依赖,后肝素增加了血脂酶活性.
- 观察到血脂,高密度胆固醇和apoA-I的显著降低.
- 观察到HDL-apolipoprotein的分数代谢率增加和脏和肝脏的apoA-I吸收增加.
结论:
- 在小鼠中EL表达提高了血脂酶活性和HDL代谢.
- 这导致HDL胆固醇和apoA-I水平下降.
- 增加的催化作用归因于和肝脏中增强的apoA-I吸收.
相关概念视频
Receptor-mediated Endocytosis
Overview
Lipid Digestion
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Absorption
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

